The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
Open accessAbstract
Allogeneic chimeric antigen receptor (CAR)-T cells hold great promise for expanding the accessibility of CAR-T therapy, whereas the risks of allograft rejection have hampered its application. Here, we genetically engineered healthy-donor-derived, CD19-targeting CAR-T cells using CRISPR-Cas9 to address the issue of immune rejection and treated one patient with refractory immune-mediated necrotizing myopathy and two patients with diffuse cutaneous systemic sclerosis with these cells. This study was registered at ClinicalTrials.gov (NCT05859997). The infused cells persisted for over 3 months, achieving complete B cell depletion within 2 weeks of treatment. During the 6-month follow-up, we observed deep remission without cytokine release syndrome or other serious adverse events in all three patients, primarily shown by the significant improvement in the clinical response index scores for the two diseases, respectively, and supported by the observations of reversal of inflammation and fibrosis. Our results demonstrate the high safety and promising immune modulatory effect of the off-the-shelf CAR-T cells in treating severe refractory autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
fastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:, Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey, W. K., Pennell, D. J., Rumberger, J. A., Ryan, T., et al. (2002) · Circulation · doi:10.1161/hc0402.102975 · Cited by 6,990
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204424 · Cited by 2,886
Bae, S., Park, J., & Kim, J.-S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu048 · Cited by 2,339
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
Talevich, E., Shain, A. H., Botton, T., & Bastian, B. C. (2016) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004873 · Cited by 2,094
The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types
Chen, T., Chen, X., Zhang, S., Zhu, J., Tang, B., Wang, A., Dong, L., Zhang, Z., Yu, C., Sun, Y., et al. (2021) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.001 · Cited by 1,816
Self-citationLUMPY: a probabilistic framework for structural variant discovery
Layer, R. M., Chiang, C., Quinlan, A. R., & Hall, I. M. (2014) · Genome Biology · doi:10.1186/gb-2014-15-6-r84 · Cited by 1,554
CRISPR-engineered T cells in patients with refractory cancer
Stadtmauer, E. A., Fraietta, J. A., Davis, M. M., Cohen, A. D., Weber, K. L., Lancaster, E., Mangan, P. A., Kulikovskaya, I., Gupta, M., Chen, F., et al. (2020) · Science · doi:10.1126/science.aba7365 · Cited by 1,478
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
Depil, S., Duchateau, P., Grupp, S. A., Mufti, G., & Poirot, L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0051-2 · Cited by 1,227
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., & Rajagopalan, S. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075005 · Cited by 1,217
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
Melenhorst, J. J., Chen, G. M., Wang, M., Porter, D. L., Chen, C., Collins, M. A., Gao, P., Bandyopadhyay, S., Sun, H., Zhao, Z., et al. (2022) · Nature · doi:10.1038/s41586-021-04390-6 · Cited by 923
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40320 · Cited by 730
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Mougiakakos, D., Krönke, G., Völkl, S., Kretschmann, S., Aigner, M., Kharboutli, S., Böltz, S., Manger, B., Mackensen, A., & Schett, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2107725 · Cited by 610
Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.005 · Cited by 581
Burt, R. K., Shah, S. J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60982-3 · Cited by 578
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
Khanna, D., Furst, D. E., Clements, P. J., Allanore, Y., Baron, M., Czirjak, L., Distler, O., Foeldvari, I., Kuwana, M., Matucci-Cerinic, M., et al. (2017) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000231 · Cited by 541
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Self-citationMapping the genomic landscape of CRISPR-Cas9 cleavage
Cameron, P., Fuller, C. K., Donohoue, P. D., Jones, B. N., Thompson, M. S., Carter, M. M., Gradia, S., Vidal, B., Garner, E., Slorach, E. M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4284 · Cited by 443
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Fugger, L., Jensen, L. T., & Rossjohn, J. (2020) · Cell · doi:10.1016/j.cell.2020.03.007 · Cited by 398
Mortality and survival in systemic sclerosis: Systematic review and meta-analysis
Rubio-Rivas, M., Royo, C., Simeón, C. P., Corbella, X., & Fonollosa, V. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.05.010 · Cited by 382
Goh, N. S., Hoyles, R. K., Denton, C. P., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40130 · Cited by 354
Partners, C.-N. M. A., Bai, X., Bao, Y., Bei, S., Bu, C., Cao, R., Cao, Y., Cen, H., Chao, J., Chen, F., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1078 · Cited by 348
Self-citationImmune-mediated necrotizing myopathy: clinical features and pathogenesis
Allenbach, Y., Benveniste, O., Stenzel, W., & Boyer, O. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00515-9 · Cited by 335
HLA-G: At the Interface of Maternal–Fetal Tolerance
Ferreira, L. M. R., Meissner, T. B., Tilburgs, T., & Strominger, J. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.009 · Cited by 291
CD19-targeted CAR T cells in refractory antisynthetase syndrome
Müller, F., Boeltz, S., Knitza, J., Aigner, M., Völkl, S., Kharboutli, S., Reimann, H., Taubmann, J., Kretschmann, S., Rösler, W., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00023-5 · Cited by 260
Kamburova, E. G., Koenen, H. J. P. M., Borgman, K. J. E., ten Berge, I. J., Joosten, I., & Hilbrands, L. B. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12220 · Cited by 257
Pecher, A.-C., Hensen, L., Klein, R., Schairer, R., Lutz, K., Atar, D., Seitz, C., Stanger, A., Schneider, J., Braun, C., et al. (2023) · JAMA · doi:10.1001/jama.2023.8753 · Cited by 251
State-of-the-art evidence in the treatment of systemic sclerosis
Pope, J. E., Denton, C. P., Johnson, S. R., Fernandez-Codina, A., Hudson, M., & Nevskaya, T. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00909-5 · Cited by 206
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., Oddis, C. V., Amato, A. A., Chinoy, H., Cooper, R. G., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211400 · Cited by 178
Mattapally, S., Pawlik, K. M., Fast, V. G., Zumaquero, E., Lund, F. E., Randall, T. D., Townes, T. M., & Zhang, J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010239 · Cited by 170
Self-citationKhanna, D., Berrocal, V. J., Giannini, E. H., Seibold, J. R., Merkel, P. A., Mayes, M. D., Baron, M. G., Clements, P. J., Steen, V. D., Assassi, S., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39501 · Cited by 160
Goldin, J. G., Elashoff, R. M., Kim, H. J., Yan, X., Lynch, D. A., Strollo, D. C., Roth, M. D., Clements, P. J., Furst, D. E., Khanna, D., et al. (2009) · CHEST Journal · doi:10.1378/chest.09-0108 · Cited by 132
Maurer, B., Graf, N., Michel, B. A., Müller‐Ladner, U., Czirják, L., Denton, C. P., Tyndall, A., Metzig, C., Lanius, V., Khanna, D., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205226 · Cited by 131
Reliability and validity of the myositis disease activity assessment tool
Sultan, S. M., Allen, E., Oddis, C. V., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23963 · Cited by 122
Alexander, T., & Greco, R. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01702-w · Cited by 114
Chimeric antigen receptor T ( CAR‐T ) cells: Novel cell therapy for hematological malignancies
Abbasi, S., Totmaj, M. A., Abbasi, M., Hajazimian, S., Goleij, P., Behroozi, J., Shademan, B., Isazadeh, A., & Baradaran, B. (2022) · Cancer Medicine · doi:10.1002/cam4.5551 · Cited by 110
Optimizing genome editing strategy by primer-extension-mediated sequencing
Yin, J., Liu, M., Liu, Y., Wu, J., Gan, T., Zhang, W., Li, Y., Zhou, Y., & Hu, J. (2019) · Cell Discovery · doi:10.1038/s41421-019-0088-8 · Cited by 108
Self-citationKhanna, D., Huang, S., Lin, C. J. F., & Spino, C. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219100 · Cited by 74
Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts
Ma, X., & Bu, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019972 · Cited by 55
Hong, C.-H., Sohn, H., Lee, H.-J., Cho, H.-I., & Kim, T. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000176 · Cited by 37
Chen, X., Tan, B.-H., Xing, H.-Z., Zhao, X., Ping, Y., Zhang, Z., Huang, J., Shi, X., Zhang, N., Lin, B., et al. (2024) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-023-03586-1 · Cited by 32
Self-citationXiong, A., Yang, G., Song, Z., Chen, X., Deng, L., Yu, S., He, L., Zhang, L., Guo, Z., & Shuai, S. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286421998918 · Cited by 28
Cited by
Du, B., Qin, J., Lin, B., Zhang, J., Li, D., & Liu, M. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.019 · Cited by 254
Self-citationProgress and challenges in developing allogeneic cell therapies
Deuse, T., & Schrepfer, S. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.03.004 · Cited by 51
Metadata
- Authors
- Wang, X., Wu, X., Tan, B., Zhu, L., Zhang, Y., Lin, L., Xiao, Y., Sun, A., Wan, X., Liu, S., Liu, Y., Ta, N., Zhang, H., Song, J., Li, T., Zhou, L., Yin, J., Ye, L., Lu, H., Hong, J., Cheng, H., Wang, P., Li, W., Chen, J., Zhang, J., Luo, J., Huang, M., Guo, L., Pan, X., Jin, Y., Ye, W., Dai, L., Zhu, J., Sun, L., Zheng, B., Li, D., He, Y., Liu, M., Wu, H., Du, B., & Xu, H.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2024-09
- Volume
- 187
- Issue
- 18
- Pages
- 4890-4904.e9
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4400651835
- Cited by
- 320
- References
- 51
- FWCI
- 49.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.